Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Press Releases
Welcome to our press release archive. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at [email protected].
Latest Press Releases
Citeline and Norstella Complete Merger to Form a $5 Billion Global Pharmaceutical Technology Company
With more than 1,600 employees across the globe, the new organization is now one of the world’s largest pharma intelligence solutions providers on the market
Evaluate Forecasts Pharmaceutical Market to be Worth $1.6tn in 2028
New World Preview report finds strong top-line growth as pricing and patent headwinds build
Citeline and Norstella Unite to Offer Life Sciences Clients a Full Suite of Commercial and Clinical Solutions
The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to…
Browse the archive
Uncertainty for pharma and biotech in 2019 as sector stumbles at the end of 2018
Vantage’s Annual Pharma and Biotech Preview explores what’s in store for 2019
Worldwide medtech sales forecast to reach $595 billion by 2024, with a CAGR of 5.6%, anchored by familiar players
Evaluate Ltd. releases annual “EvaluateMedtech World Preview 2018, Outlook to 2024” in conjunction with The Medtech Conference
Small drug developers continue to hold all the cards, while young device makers suffer from a shrinking pool of buyers
Vantage releases its half-year analysis of sector performance: Pharma, Biotech and Medtech Half-Year Review 2018
Worldwide Prescription Drug Sales Accelerate To $1.2 Trillion By 2024, As Unmet Need Drives Annual Compound Growth To Over 6%
Eleventh annual EvaluatePharma World Preview 2018, Outlook to 2024 report launches at BIO 2018.
Worldwide Orphan Drug Sales Are Forecast To Grow At A Cagr Of 11.3% From 2018 To 2024, Double The Rate Forecast For The Non-Orphan Drug Market
Annual “EvaluatePharma Orphan Drug 2018 Report” sees Orphan drugs capture a fifth of worldwide prescription sales by 2024 as sales grow to $262bn.
Fast Pace Of Drug And Device Approvals In 2017 Signals Wider Sector Health For Biopharma But Medtech Companies Struggle
EP Vantage releases its annual analysis of sector performance: Pharma, Biotech and Medtech 2017 in Review.
Uptick In M&A Activity And Investor Cash Expected To Re-Invigorate Pharma And Biotech In 2018
EP Vantage’s Annual Pharma and Biotech Preview explores what’s in store for 2018.
Worldwide Medtech Sales Forecast To Reach $522 Billion By 2022 With A Cagr Of 5.1% Between 2016 And 2022
EvaluateMedTech Report Launches in Conjunction with The MedTech Conference.
Biopharma Stages A Strong Recovery Over The First Half Even As M&A Deals Disappoint, While Unprecedented Amounts Of Money Flow In Medtech But Not Towards Smaller Innovators
EP Vantage Releases Half-Year Reviews of Pharma & Biotech and Medtech Performance.
